CAMP4 Therapeutics Receives $30 Million Series A to Continue Developing Unique Discovery Platform

CAMP4 Therapeutics  is on a mission to modernize the way the pharma industry discovers new treatments. Operating at the intersection of biology and computation, CAMP4 is building on seminal discoveries in gene regulation circuitry made by Company founders, Dr. Richard Young (Whitehead Institute/MIT) and Dr. Leonard Zon (Boston Children’s Hospital/Harvard University).